These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 38907157)

  • 1. Regulations of m
    Chen XH; Guo KX; Li J; Xu SH; Zhu H; Yan GR
    Front Med; 2024 Aug; 18(4):622-648. PubMed ID: 38907157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection and functions of RNA modification m
    Zhang W; Qian Y; Jia G
    J Biol Chem; 2021 Aug; 297(2):100973. PubMed ID: 34280435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of m
    Nombela P; Miguel-López B; Blanco S
    Mol Cancer; 2021 Jan; 20(1):18. PubMed ID: 33461542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Chen M; Chen Y; Wang K; Deng X; Chen J
    Clin Transl Med; 2024 Jun; 14(6):e1666. PubMed ID: 38880983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA methylation: A potential therapeutic target in autoimmune disease.
    Li L; Xia X; Yang T; Sun Y; Liu X; Xu W; Lu M; Cui D; Wu Y
    Int Rev Immunol; 2024 May; 43(3):160-177. PubMed ID: 37975549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modification of m
    Wang Y; Wang Y; Patel H; Chen J; Wang J; Chen ZS; Wang H
    Mol Cancer; 2023 Jun; 22(1):102. PubMed ID: 37391814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Writers, readers, and erasers RNA modifications and drug resistance in cancer.
    Chen D; Gu X; Nurzat Y; Xu L; Li X; Wu L; Jiao H; Gao P; Zhu X; Yan D; Li S; Xue C
    Mol Cancer; 2024 Aug; 23(1):178. PubMed ID: 39215288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of RNA methylation in tumor immunity and its potential in immunotherapy.
    Li Y; Jin H; Li Q; Shi L; Mao Y; Zhao L
    Mol Cancer; 2024 Jun; 23(1):130. PubMed ID: 38902779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.
    Haran V; Lenka N
    Stem Cell Rev Rep; 2019 Aug; 15(4):474-496. PubMed ID: 31123982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reading, writing and erasing mRNA methylation.
    Zaccara S; Ries RJ; Jaffrey SR
    Nat Rev Mol Cell Biol; 2019 Oct; 20(10):608-624. PubMed ID: 31520073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA m
    Tong J; Flavell RA; Li HB
    Front Med; 2018 Aug; 12(4):481-489. PubMed ID: 30097961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of RNA modification and long noncoding RNA interaction in cancer.
    Yang L; Tang L; Min Q; Tian H; Li L; Zhao Y; Wu X; Li M; Du F; Chen Y; Li W; Li X; Chen M; Gu L; Sun Y; Xiao Z; Shen J
    Cancer Gene Ther; 2024 Jun; 31(6):816-830. PubMed ID: 38351139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of RNA N
    Chang G; Leu JS; Ma L; Xie K; Huang S
    Cytokine; 2019 Jun; 118():35-41. PubMed ID: 30017390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of m
    Benak D; Benakova S; Plecita-Hlavata L; Hlavackova M
    Front Endocrinol (Lausanne); 2023; 14():1223583. PubMed ID: 37484960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of antiviral innate immunity through non-m
    Shen S; Zhang LS
    Front Immunol; 2023; 14():1286820. PubMed ID: 37915585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Insights into N
    Huang J; Yin P
    Genomics Proteomics Bioinformatics; 2018 Apr; 16(2):85-98. PubMed ID: 29709557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA modifications and cancer.
    Haruehanroengra P; Zheng YY; Zhou Y; Huang Y; Sheng J
    RNA Biol; 2020 Nov; 17(11):1560-1575. PubMed ID: 31994439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives.
    Chen Y; Jiang Z; Yang Y; Zhang C; Liu H; Wan J
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126773. PubMed ID: 37690652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.